Health Care • Medical/Dental Instruments
$321.34 ▲ +2.39
(+0.75%)
MKT CAP: $12.57B • VOL: 463.6K
52W L $221 52W H $362
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$270
MEDIAN
$360
MEAN
$366
HIGH
$437
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE PEN TAPE
PEN // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $388.82 | $369.54 | 2025-02-14 | $292.42 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $404.89 | $379.18 | 2025-02-06 | $302.06 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $366.33 | $353.47 | 2025-01-29 | $308.49 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $327.77 | — | 2025-01-17 | $314.91 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $282.78 | $305.27 | 2025-01-09 | $285.99 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $382.39 | $334.19 | 2024-12-18 | $279.57 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $311.70 | $324.55 | 2024-12-04 | $298.85 | -4.3% | 48% | C |